Cover Image

Consolidative mediastinal irradiation of malignant lymphoma using active scanning proton beams: clinical outcome and dosimetric comparison

Current research approaches in lymphoma focus on reduction of therapy-associated long-term side effects. Especially in mediastinal lymphoma, proton beam radiotherapy (PT) may be a promising approach for reducing the dose to organs at risk (OAR).

Saved in:
Bibliographic Details
Main Authors: König, Laila (Author) , Bougatf, Nina (Author) , Hörner-Rieber, Juliane (Author) , Chaudhri, Naved Sarwar (Author) , Mielke, Thomas (Author) , Klüter, Sebastian (Author) , Häfner, Matthias (Author) , Rieken, Stefan (Author) , Haberer, Thomas (Author) , Debus, Jürgen (Author) , Herfarth, Klaus (Author)
Format: Article (Journal)
Language:English
Published: :10 April 2019
In: Strahlentherapie und Onkologie
Year: 2019, Volume: 195, Issue: 7, Pages: 677-687
ISSN:1439-099X
DOI:10.1007/s00066-019-01460-7
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/s00066-019-01460-7
Get full text
Author Notes:Laila König, Nina Bougatf, Juliane Hörner-Rieber, Naved Chaudhri, Thomas Mielke, Sebastian Klüter, Matthias Felix Haefner, Stefan Rieken, Thomas Haberer, Jürgen Debus, Klaus Herfarth
Description
Summary:Current research approaches in lymphoma focus on reduction of therapy-associated long-term side effects. Especially in mediastinal lymphoma, proton beam radiotherapy (PT) may be a promising approach for reducing the dose to organs at risk (OAR).
Item Description:Gesehen am 21.04.2020
Physical Description:Online Resource
ISSN:1439-099X
DOI:10.1007/s00066-019-01460-7

Similar Items